大规模的全外基因组测序研究确定了两个与肺癌相关的基因,CTSL和APOE
Jingxiong Xu1, Wei Xu2,3, Jiyeon Choi4
1Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Ontario, Canada.
PLoS genetics
|September 22, 2023
概括
罕见的遗传变异对肺癌风险有显著的贡献,CTSL和APOE被确定为关键基因. 对这些变体的进一步研究可能会为肺癌患者揭示新的治疗点.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
背景情况:
- 常见的遗传变异解释了有限的肺癌遗传性 (12.3%).
- 罕见变异 (RVs) 在肺癌病因学中的作用尚未得到充分研究.
- 整体外基因组测序 (WES) 提供了一个强大的工具来识别RVs.
研究的目的:
- 调查罕见变异对肺癌易感性的贡献.
- 为了确定隐藏与肺癌相关的RVs的特定基因.
- 评估已识别的RVs的潜在治疗影响.
主要方法:
- 采用了两项大型整体外基因组测序病例控制研究.
- 进行基因相关性测试,使用新的贝叶斯因子统计.
- 在发现 (国际肺癌联盟) 和复制 (英国生物银行) 队列中的验证结果.
主要成果:
- 在这两个研究队伍中,确定了CTSL和APOE作为与肺癌显著相关的基因.
- 在CTSL和APOE中发现了多种罕见变异 (RV),与肺癌有很强的关联.
- 观察到的显著赔率比率 (ORs) 在已识别的RV中从2.0到139.0不等.
结论:
- 罕见的CTSL和APOE变异与肺癌风险显著相关.
- 这些发现凸显了肺癌罕见遗传变异的重要性.
- 对这些变体的功能作用的进一步研究可能会提供治疗途径.
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K


